Iovance Biotherapeutics
IOVA
IOVA
77 hedge funds and large institutions have $183M invested in Iovance Biotherapeutics in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 17 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
31% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 16
33% less capital invested
Capital invested by funds: $271M → $183M (-$88.7M)
Holders
77
Holding in Top 10
2
Calls
$2.95M
Puts
$422K
Top Buyers
| 1 | +$4.04M | |
| 2 | +$2.97M | |
| 3 | +$1.66M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$1.27M |
| 5 |
QF
QVT Financial
New York
|
+$836K |
Top Sellers
| 1 | -$3.82M | |
| 2 | -$1.54M | |
| 3 | -$1.08M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$882K |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$317K |